Journey Medical (DERM): Rega marang dodolan

Steady demand for approved dermatological brands at Journey Medical (DERM) ensures sustainable revenue, as reflected in the company's P/S ratio dynamics, where the indicator reaches 1.40. The optimization of regional warehouses supports retail profitability by preventing drug shortages. Simultaneously, the business minimizes its environmental footprint through plastic recycling and strict compliance with waste disposal regulations.

Rasio rega marang pendapatan: Journey Medical Corp (DERM) kanggo 04.07.2022 - 13.11.2026

Rincian analitis perusahaan Journey Medical (DERM)

- kuotasi lan prakiraan analis:

Rega journeymedicalcorp.com|DERM - Bagan rega target

- data kapitalisasi bursa:

Nilai pasar Journey Medical Corp.|DERM - Rega Nyata Tumbas Perusahaan Kanthi Wutuh

- data nilai buku modal saham:

Nilai Buku saben Saham Journey Medical|DERM - Nilai Buku Perusahaan|Nilai Pasar marang Nilai Buku journeymedicalcorp.com|DERM - Aset Agregat Perusahaan

- rincian struktur utang lan likuiditas bisnis:

Rasio Utang marang Ekuitas Journey Medical|DERM - Utang jangka dawa marang modal|Kewajiban jangka cendhak marang modal journeymedicalcorp.com|DERM - Gunggung utang perusahaan|Utang-utang marang nilai buku Journey Medical Corp.|DERM - Kewajiban jangka dawa perusahaan|Silihan lan utang jangka cendhak perusahaan Journey Medical|Indikator likuiditas cepet journeymedicalcorp.com

- indikator profitabilitas perusahaan lan kelipatan valuasi:

DERM - Bathi resik|Bathi resik sing dikarepake Journey Medical|DERM - Pangali P/E|Rasio rega marang bathi mangsa ngarep journeymedicalcorp.com|DERM - Pangali PEG|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Journey Medical Corp.|DERM - Bathi operasional EBITDA|Bathi resik saben saham sajrone 12 wulan pungkasan Journey Medical|DERM - Bathi resik saben saham (EPS TTM)|Wutah bathi EPS kuartalan journeymedicalcorp.com|DERM - Wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Journey Medical

- data total pendapatan lan volume dodolan:

DERM - Pendapatan lan volume dodolan|Prakiraan pendapatan perusahaan journeymedicalcorp.com|DERM - Multiplikator P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Journey Medical Corp.

Ringkesan analitik perusahaan:DERM - Journey Medical Corp

Produk sing diprodhuksi Journey Medical Corp.

The operating model of Journey Medical (DERM) is reflected in the shifting P/S multiple amid geopolitical risks and substance supply chain disruptions. This indicator compares market capitalization to annual revenue, allowing investors to assess the premium paid for the asset and the business value's sensitivity to external shocks, excluding debt load or accounting distortions.

Karo sapa Journey Medical saingan

Kapitalisasi marang volume dodolan KRYS|Rasio rega marang pendapatan Apogee Therapeutics, Inc. APGE|Arcutis (ARQT) - Rega marang dodolan|VCEL: Kapitalisasi marang pendapatan|ORKA - Multiplikator P/S|sanaramedtech.com (SMTI) - Rasio rega marang pendapatan|DBV Technologies - Rasio kapitalisasi pasar marang pendapatan|Rasio rega marang pendapatan Solesence Beauty|Rasio kapitalisasi marang pendapatan FBRX (Forte Biosciences Inc.)|Multiplikator P/S EMPG|SLGL - Rega marang dodolan|AXIL Brands - Kapitalisasi marang pendapatan|medicuspharma.com (MDCX) - Rega marang dodolan|VRCA: Kapitalisasi marang pendapatan|Rasio kapitalisasi pasar marang pendapatan HOTH (Hoth Therapeutics, Inc.)|biofrontera-us.com (BFRI) - Rasio rega marang pendapatan|Kapitalisasi marang pendapatan VYNE Therapeutics Inc.|SNOA (Sonoma Pharmaceuticals Inc.) - Multiplikator P/S|Rega marang dodolan Quoin Pharma QNRX|Multiplikator P/S AZTR|Dermata Therapeutics Inc - Rasio kapitalisasi marang pendapatan|Multiplikator P/S ELAB (Elevai Skincare)|Koefisien rega marang pendapatan Revance Therapeutics Inc (RVNC)